Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bausch Health
Biotech
Merck poaches marketing chief from Biogen—Chutes & Ladders
Biogen marketing exec returns to his Merck & Co. roots. PathAI's co-founder charts a new course. And Ellume's U.S. president joins American Gene.
Fraiser Kansteiner
Jun 24, 2022 9:30am
Bausch Health pulls the plug on Solta Medical IPO
Jun 17, 2022 10:50am
Bausch Health files for Solta IPO as its 3-way split nears goal
Feb 9, 2022 9:30am
Bausch + Lomb files IPO for its eye care spinout
Jan 14, 2022 10:45am
Bausch-Novaliq's eye drop beats placebo again in phase 3 trial
Sep 30, 2021 11:00am
Bausch Health sets up IPO for aesthetics medtech Solta Medical
Aug 3, 2021 11:33am
